Terns

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

pharmaceutical giant Merck Acquires US biotechnology company Terns Pharmaceuticals It cost $6.7 billion, the company said Wednesday. This is Merck’s…